Proopiomelanocortin processing in corticotroph cells is known to be operated by prohormone convertase (PC) 1/3 which is activating several pro-proteins and prohormones by intracellular limited proteolysis processing. In this study, we hypothesized that PC1/3 expression differs between Cushing's disease (CD) and silent corticotroph adenoma (SCA), and investigated whether PC1/3 expression is involved in the adrenocorticotropin (ACTH) silence of SCA. We performed immunohistochemical analysis of pituitary adenoma specimens for six adenohypophysial hormones, PC1/3 and chromogranin A (CgA). Subjects for this study consisted of 12 anterior pituitary adenomas of CD (1 male, 11 female; 14-70 years old) and 31 non-functioning adenomas (23 male, 8 female; 32-71 years old).ACTH immunoreactivity was observed in all of CD and three of 31 non-functioning adenomas. The three cases diagnosed as SCA were also positive for growth hormone and follicle-stimulating hormone. Cushing's adenomas and SCAs were all positive for PC1/3. PC1/3-positive cells did not always colocalize with ACTH but some of them colocalized with CgA in SCAs. Even if PC1/3 is not present in corticotroph cells, PC1/3 immunoreactivity in SCA may originate from CgA-positive cells. We conclude that immunohistochemistry for PC1/3 is not helpful for differential diagnosis between CD and SCA in clinical practice, though the regulation of PC1/3 expression is likely to be an important etiological factor in ACTH silence of SCA. The diversity of immunohistochemical properties of SCA leads us to speculate that it is not a single entity and may be a general diagnostic term for adenomas of varying etiology.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11102-007-0010-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs.
Sci Rep
October 2024
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA.
Insulin secretion is impaired in individuals with cystic fibrosis (CF), contributing to high rates of CF-related diabetes (CFRD) and substantially increasing disease burden. To develop improved therapies for CFRD, better knowledge of pancreatic pathology in CF is needed. Glucagon like peptide-1 (GLP-1) from islet α cells potentiates insulin secretion by binding GLP-1 receptors (GLP-1Rs) on β cells.
View Article and Find Full Text PDFAblation of PC1/3 in POMC-Expressing Tissues but Not in Immune Cells Induces Sepsis Hypersensitivity.
J Endocr Soc
September 2024
Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.
Prohormone convertase 1/3 (PC1/3) is an endopeptidase required for the processing of neuropeptide and endocrine peptide precursors; it is expressed in neuroendocrine tissues as well as in immune cells. In response to endotoxemia, global PC1/3 knockout mice mount a cytokine storm and die rapidly. Further, immune cells isolated from these mice have a pro-inflammatory signature, suggesting that PC1/3 activates an unknown anti-inflammatory peptide precursor in immune cells.
View Article and Find Full Text PDFQuantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.
Diabetologia
December 2024
Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
Article Synopsis
- This study investigates how the expression of prohormone convertase 1/3 (PC1/3), an enzyme crucial for processing peptide hormones, is affected in islet cells during the progression of type 1 and type 2 diabetes.
- Researchers analyzed pancreatic samples from a diverse group of 54 donors, using immunostaining for detailed examination of PC1/3 in various islet cells at different diabetes stages.
- The results revealed significant changes in islet cell morphology and reduced co-localization of PC1/3 with insulin in type 1 diabetes, while an increase in glucagon and somatostatin in these islets was also noted.
Fam3a-mediated prohormone convertase switch in α-cells regulates pancreatic GLP-1 production in an Nr4a2-Foxa2-dependent manner.
Metabolism
January 2025
Department of Endocrinology and Metabolism, State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing 100191, China. Electronic address:
Article Synopsis
- - The study explores the role of Fam3a in pancreatic α-cell function, particularly its impact on glucagon and GLP-1 levels, using both global and α-cell-specific knockout models.
- - Researchers conducted experiments on αTC1.9 cells to determine how Fam3a influences the expression of PCSK1, which is crucial for converting proglucagon into GLP-1, revealing a regulatory pathway involving the proteins Nr4a2 and Foxa2.
- - Results indicated that Fam3a knockout enhanced GLP-1 levels in mice, while human islet data suggested an inverse relationship between FAM3A and PCSK1, highlighting Fam3a's potential role as a negative regulator of GL
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!